LOUISVILLE, KY and CLEVELAND, OH – EmsanaRx, a public benefit corporation, and Cleveland Clinic have announced a first-of-its-kind strategic affiliation today. This collaboration will align EmsanaRx with Cleveland Clinic to further both organizations’ mission of providing cost-effective, high-quality care.
Cleveland Clinic will advise clinicians and multidisciplinary teams at EmsanaRx to support the company’s formulary development and utilization management programs and inform some of its benefit offerings. The health system will provide outside perspective on the clinical value of new and existing medications, treatments and therapies, based on its best practices for patient care and expertise in the latest technologies and innovations in healthcare.
This strategic affiliation creates opportunities to provide new treatments to patients, lower prescription drug costs, and expand clinical programs. Its goals include delivering reliable information, and improving quality and patient satisfaction to EmsanaRx’s large employer clients and the lives they serve. EmsanaRx will ensure members’ needs are met and drive clinical decision making.
“Through this collaboration, we can improve how effectively we serve our large employer clients. Management of pharmacy benefits is complex. EmsanaRx provides a better member experience with less disruption and we can advance the industry to benefit our communities by working together on programs like this,” said Greg Baker, co-founder and CEO of EmsanaRx. “This agreement allows us to remain true to our mission and vision by bringing a world class clinical expertise to drive superior outcomes.”
As the only pharmacy benefit manager (PBM) built by employers, EmsanaRx’s mission is to bring clarity, integrity and trust to pharmacy benefit management. EmsanaRx is committed to delivering a clinically focused, transparent and easy-to-use pharmacy benefit experience to its members.
“Cleveland Clinic is bringing to this affiliation a patients-first approach to EmsanaRx in a time where employers and individuals are increasingly sensitive to the rise in pharmacy spending. We prioritize transparency, quality care and improving the health of every population and believe this partnership will further those efforts,” Bruce Rogen, M.D., chief medical officer, Cleveland Clinic Employee Health Plan, commented.
EmsanaRx is the first company launched by Emsana Health, an innovation studio created by the Purchaser Business Group on Health (PBGH) to tackle the largest problems facing employers today. PBGH is a nonprofit coalition of nearly 40 large private employers and public healthcare purchasers committed to transforming healthcare nationwide.
“Our members told us they find most pharmacy benefits programs to be opaque, increasingly expensive and of varying clinical quality. They asked us to come up with a better solution,” said Elizabeth Mitchell, president and CEO of PBGH. “Large employers are very interested in EmsanaRx’s work to bring pharmacy benefit management back in line with the needs of their employees by offering greater flexibility and the ability to manage their drug spending. We believe working with Cleveland Clinic can help employers achieve this.”
EmsanaRx: Katie Marks, Katie@emsanaRx.com, 502.494.0122
Cleveland Clinic: Katrina Healy, firstname.lastname@example.org, 216.386.0955